Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-319303
Filing Date
2025-12-15
Accepted
2025-12-15 16:39:20
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4797
  Complete submission text file 0001193125-25-319303.txt   6279
Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Behbahani Ali (Reporting) CIK: 0001613867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 251572140

Mailing Address 245 FIRST STREET, 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 18TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 814254660 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)